Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Wound care specialist Advanced Medical Solutions has confirmed that it is trading in line with its own expectations but has warned that customer de-stocking because of Brexit is starting to have an impact.
Strong growth has been seen in the majority of the company's product ranges and geographies but more rapid growth has been held back by slowing sales of LiquiBand as some customers run down existing stocks built-up ahead of Brexit.
Doubts about access to key products as in a post-Brexit environment had led many customers to bolster stocks over recent months.
Chris Meredith, chief executive of Advanced Medical Solutions remains upbeat on the longer-term picture.
'We are excited about the growth prospects for the business, the integration of Sealantis and the expected impact from new product launches', he said.
At 9:03am: (LON:AMS) Advanced Medical Solutions Group PLC share price was -18.5p at 301.5p